Header Logo

Connection

Gary Reubenson to Treatment Outcome

This is a "connection" page, showing publications Gary Reubenson has written about Treatment Outcome.
Connection Strength

0,177
  1. Pediatric drug-resistant tuberculosis: a global perspective: a global perspective. Paediatr Drugs. 2011 Dec 01; 13(6):349-55.
    View in: PubMed
    Score: 0,079
  2. Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network. J Acquir Immune Defic Syndr. 2017 Jun 01; 75(2):156-163.
    View in: PubMed
    Score: 0,029
  3. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study. Lancet Glob Health. 2017 03; 5(3):e359-e369.
    View in: PubMed
    Score: 0,028
  4. Poor early virologic performance and durability of abacavir-based first-line regimens for HIV-infected children. Pediatr Infect Dis J. 2013 Aug; 32(8):851-5.
    View in: PubMed
    Score: 0,022
  5. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet. 2010 May 22; 375(9728):1798-807.
    View in: PubMed
    Score: 0,018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.